These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
525 related articles for article (PubMed ID: 19795775)
1. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz. Morsy GH J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775 [TBL] [Abstract][Full Text] [Related]
2. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice. Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111 [TBL] [Abstract][Full Text] [Related]
3. Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment. Botros SS; Hammam O; Mahmoud M; Bergquist R APMIS; 2010 Sep; 118(9):692-702. PubMed ID: 20718722 [TBL] [Abstract][Full Text] [Related]
4. Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection. William S; Guirguis F; Nessim NG Arzneimittelforschung; 2003; 53(7):532-7. PubMed ID: 12918221 [TBL] [Abstract][Full Text] [Related]
5. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni. Nessim NG; Demerdash Z Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment. Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535 [TBL] [Abstract][Full Text] [Related]
7. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni. El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203 [TBL] [Abstract][Full Text] [Related]
8. Antischistosomal effects of praziquantel, its alkaline hydrolysis and sun decomposed products on experimentally S. mansoni infected albino mice. (A) Efficacy assessment based on clinicopathological findings. Suleiman MI; Akarim EI; Ibrahim KE; Saad AM; Mohammed AE; Ahmed BM; Sulaiman SM J Egypt Soc Parasitol; 2004 Apr; 34(1):131-42. PubMed ID: 15143740 [TBL] [Abstract][Full Text] [Related]
9. Immunohistopathological and biochemical changes in Schistosoma mansoni-infected mice treated with artemether. Botros SS; Mahmoud MR; Moussa MM; Nosseir MM J Infect; 2007 Nov; 55(5):470-7. PubMed ID: 17868901 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni. el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553 [TBL] [Abstract][Full Text] [Related]
11. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile. Farid A; Malek AA; Rabie I; Helmy A; El Amir AM Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice. Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy. Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014 [TBL] [Abstract][Full Text] [Related]
14. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates. Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853 [TBL] [Abstract][Full Text] [Related]
15. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo. Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638 [TBL] [Abstract][Full Text] [Related]
16. Oltipraz treatment in experimental schistosomiasis mansoni: III. Effect of high dose oral therapy on hepatic shift of worms and tissue bound ova pattern in infected mice. Aboul-Atta AM; Hassan ZA; el-Ahl SS J Egypt Soc Parasitol; 1989 Dec; 19(2):641-51. PubMed ID: 2504827 [TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice. Giboda M; Smith JM J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010 [TBL] [Abstract][Full Text] [Related]
18. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay. Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. El-Lakkany NM; Hammam OA; El-Maadawy WH; Badawy AA; Ain-Shoka AA; Ebeid FA Parasit Vectors; 2012 Jan; 5():9. PubMed ID: 22236605 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni. Mohammad OS; Hussein HM; Abdel-Sayed SW; Mohamed GA; Shehata MAS Parasitol Res; 2024 May; 123(5):215. PubMed ID: 38771511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]